Distribution of β-lactamases and emergence of carbapenemases co-occurring Enterobacterales isolates with high-level antibiotic resistance identified from patients with intra-abdominal infection in the Asia–Pacific region, 2015

Distribution of β-lactamases and emergence of carbapenemases co-occurring Enterobacterales isolates with high-level antibiotic resistance identified from patients with intra-abdominal infection in the Asia–Pacific region, 2015–2018

Published:2021-07 Issue: Volume: Page:
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Chen Yu-Chin,Chen Wei-Yu,Hsu Wei-Yun,Tang Hung-Jen,Chou Yun,Chang Yi-Hsin,Chen Chi-Chung,Chuang Yin-Ching,Chang Tu-Hsuan^ORCID

Funder

Merck Sharp and Dohme

Chi Mei Medical Center

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference40 articles.

1. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018;Lee;Int J Antimicrob Agents,2019

2. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program;Diekema;Antimicrob Agents Chemother,2019

3. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Gautret;Int J Antimicrob Agents,2020

4. The epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections;Kuo;J Microbiol Immunol Infect,2018

5. Citrobacter freundii bacteremia: risk factors of mortality and prevalence of resistance genes;Liu;J Microbiol Immunol Infect,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–21;International Journal of Antimicrobial Agents;2024-04

2. High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–2021;International Journal of Antimicrobial Agents;2024-04

3. In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016–2020;Journal of Global Antimicrobial Resistance;2024-03

4. Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021;Frontiers in Public Health;2023-12-07

5. Emergence and dissemination of multidrug-resistant Escherichia coli ST8346 coharboring blaNDM-5 and blaOXA-181 in Southern Taiwan, 2017–2021;Journal of Infection and Public Health;2023-10